AARON TYNER: Open Payments
NPI 1902319239 · SAINT JOSEPH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,288 in 35 payments from 14 companies in 2025. Trend: 2023 $616 · 2024 $542 · 2025 $1,288
Food & beverage: $1,288
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 9 | $260 |
| Edwards Lifesciences Corporation | 2 | $245 |
| Boston Scientific Corporation | 2 | $150 |
| Novartis Pharmaceuticals Corporation | 6 | $141 |
| Abbott Laboratories | 1 | $138 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| BridgeBio Pharma, Inc. | 2 | $67 |
| Amgen Inc. | 2 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Novo Nordisk Inc | 1 | $26 |
Products named: AMVUTTRA, WATCHMAN Access System, LEQVIO, XIENCE SKYPOINT, EVOQUE, Attruby, CAMZYOS, REPATHA.
Industry payments across MI — which companies pay providers there.
